HELIOS Kliniken

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial (2016) Herrlinger U, Schaefer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, et al. Journal article Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases (2016) Klement RJ, Allgaeuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, et al. Journal article Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients (2016) Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, et al. Journal article Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy (2016) Guckenberger M, Klement RJ, Allgaeuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, et al. Journal article High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) (2016) Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Moehle R, Loew S, et al. Journal article Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial (2016) Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Sunderkoetter C, Kaatz M, et al. Journal article Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01) (2016) Kasper B, Gruenwald V, Reichardt P, Bauer S, Hohenberger P, Haller F Journal article Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome (2016) Voelkl S, Rensing-Ehl A, Allgäuer A, Schreiner E, Lorenz MR, Rohr J, Klemann C, et al. Journal article Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011 (2016) Schoffer O, Schuelein S, Arand G, Arnholdt H, Baaske D, Bargou RC, Becker N, et al. Journal article Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study (2016) Stallmach A, Langbein C, Atreya R, Bruns T, Dignass A, Ende K, Hampe J, et al. Journal article